AFT Pharmaceuticals Limited Share Price and Company Fundamentals
Last traded: Today at 4:59 AM
AFT Pharmaceuticals Limited, together with its subsidiaries, develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally. The company offers proprietary and in-licensed products, including patented, branded, and generic drugs; and products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, natural health, pain management, skin care, sleeping aids, supplements, and other products. It has a research and development collaboration with Hyloris Pharmaceuticals SA for the development of the Maxigesic IV product. AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.
Key Metrics
PE ratio
26.07
PB ratio
3.47
Dividend yield
-
Beta
0.42
Market cap
$382.76M
Enterprise value
$445.34M
Company profile
| Industry / Sector | Drug Manufacturers - Specialty & Generic / Healthcare |
|---|---|
| Full time employees | 126 |
| Website | https://www.aftpharm.com |
| Mailing address | 129 Hurstmere Road Level 1 Takapuna Auckland 0622 New Zealand |
| Phone / Fax | 64 8 0042 3823 / 64 8 0042 3874 |
Dividends
Dividend yield
-
Dividend amount
$-
Payout ratio
-
5Y Avg. yield
-%
AFT Pharmaceuticals Limited paid $- dividend and the ex-dividend date was -.The dividend payout ratio is -. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.
Company Executives
As of Jun 2026, following are the company executives and directors listed on AFT Pharmaceuticals Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Dr. Hartley Atkinson Ph.D. | Co-Founder, CEO, MD & Executive Director | ||
| Ms. Marree Atkinson | Co-Founder, Chief of Staff & Executive Director | ||
| Ms. Ioana Stanescu | Chief Scientific Officer | ||
| Mr. Murray Keith | Group Marketing Manager |
Profitability and management effectiveness
Profit margin
5.78%
Operating margin
14.10%
Return on assets
7.90%
Return on equity
13.66%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of AFT Pharmaceuticals Limited is 382.76M and its enterprise value is 445.34M. The enterprise value to revenue ratio of AFT is 1.75. The enterprise value to EBITDA ratio of AFT is 17.91.
The AFT's stocks Beta value is 0.42 making it 58% less volatile compared to NZX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
AFT Pharmaceuticals Limited (NZX:AFT) Frequently Asked Questions
1. What is AFT Pharmaceuticals Limited's Stock Symbol?
AFT Pharmaceuticals Limited trades on NZX under the ticker symbol "AFT".
2. What is AFT Pharmaceuticals Limited's stock price today?
One share of AFT stock can currently be purchased for approximately $3.65.
3. How can I contact AFT Pharmaceuticals Limited?
AFT Pharmaceuticals Limited's mailing address is 129 Hurstmere Road Level 1 Takapuna Auckland 0622 New Zealand. The company can be reached via phone at 64 8 0042 3823.
4. What is AFT Pharmaceuticals Limited's official website?
The official website of AFT Pharmaceuticals Limited is https://www.aftpharm.com.